Nektar Therapeutics
Символ: NKTR
NASDAQ
0.9
USDПазарна цена днес
-0.9135
Съотношение P/E
-0.0130
Коефициент PEG
165.26M
MRK Cap
- 0.00%
Доходност на DIV
Nektar Therapeutics Структура на управлението
Информация за управлението
Име | Заглавие |
---|---|
Ms. Sandra A. Gardiner | Interim Chief Financial Officer |
Mr. Mark A. Wilson | Senior Vice President, Chief Legal Officer & Secretary |
Dr. Jonathan Zalevsky Ph.D. | Chief Research & Development Officer |
Dr. Mary Tagliaferri L.Ac., M.D. | Chief Medical Officer |
Ms. Jennifer Ruddock | Chief Business Officer |
Mr. Howard W. Robin | Chief Executive Officer, President & Director |
Mr. Robert Bacci | Senior Vice President of Human Resources & Facilities Operations |
Vivian Wu | Director of Investor Relations & Corporate Affairs |
Подобни акции
Може да се интересувате и от:MRVI
Топ мениджмънт:
- Mr. Christopher ...
- Ms. Debra Hart
- Ms. Becky Buzzeo
CMRA
Топ мениджмънт:
- Ms. Janice Marie ...
- Dr. David Soane ...
- Mr. Michael G. Ca...
T5O.DE
Топ мениджмънт:
- Dr. Mark-André F...
- Dr. Dirk Kaiser
- Dr. Bruno Rosen
PPBT
Топ мениджмънт:
- Mr. Ido Morpurgo...
- Mr. Lior Fhima C...
- Dr. Michael Schi...
SPHRF
Топ мениджмънт:
- Ms. Cheryl Maley...
- Mr. Justin Cahill
ARQT
Топ мениджмънт:
- Ms. Courtney Barton
- Ms. Ayisha Jeter
- Ms. Amanda Sheldon